Palvella Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	57.98	83.6	7.35	16.05
Cash & Short-Term Investments	57.98	83.6	7.35	16.05
Cash Growth	-30.64%	1037.44%	-54.21%	-
Accounts Receivable	-	0.36	-	-
Other Receivables	-	1.98	-	-
Receivables	-	2.34	-	-
Prepaid Expenses	1.01	2.3	0.2	0.47
Total Current Assets	58.99	88.23	7.55	16.52
Property, Plant & Equipment	0.57	-	-	-
Total Assets	59.56	88.23	7.55	16.52
Accounts Payable	4.6	4.59	0.94	3.18
Accrued Expenses	3.65	4.29	1.26	2.44
Current Portion of Leases	0.2	-	-	-
Other Current Liabilities	2.9	3.17	0.17	0.16
Total Current Liabilities	11.34	12.04	2.36	5.78
Long-Term Debt	17.76	11.94	8.05	32.42
Long-Term Leases	0.43	-	-	-
Other Long-Term Liabilities	2.04	1.65	1.01	1.5
Total Liabilities	31.58	25.63	11.43	39.7
Common Stock	0.01	0.01	-	-
Additional Paid-In Capital	163.34	156.33	1.82	1.22
Retained Earnings	-135.45	-93.74	-76.3	-94.99
Comprehensive Income & Other	0.08	0	-	-
Total Common Equity	27.98	62.61	-74.48	-93.78
Shareholders' Equity	27.98	62.61	-3.88	-23.17
Total Liabilities & Equity	59.56	88.23	7.55	16.52
Total Debt	18.39	11.94	8.05	32.42
Net Cash (Debt)	39.59	71.66	-0.7	-16.36
Net Cash Growth	-44.75%	-	-	-
Net Cash Per Share	3.52	32.19	-0.39	-2.86
Filing Date Shares Outstanding	14.31	11.02	5.72	5.72
Total Common Shares Outstanding	12.38	11.01	5.72	5.72
Working Capital	47.64	76.2	5.19	10.74
Book Value Per Share	2.26	5.69	-13.02	-16.40
Tangible Book Value	27.98	62.61	-74.48	-93.78
Tangible Book Value Per Share	2.26	5.69	-13.02	-16.40

Source: S&P Capital IQ. Standard template. Financial Sources.